Get the latest Science News and Discoveries
First cardiac bioimplants for the treatment of patients with myocardial infarction using umbilical cord stem cells - EurekAlert
<p>The results of a pioneering study support the safety of the bioimplants called PeriCord, made from stem cells of the umbilical cord and pericardium from a tissue donor, which aid in the regeneration and revascularisation of the affected area.</p> <p>The study has monitored 7 interventions of this pioneering tissue engineering surgery over three years, noting excellent biocompatibility and no rejection in patients.</p> <p>The therapy has been developed by the research group ICREC (Heart Failure and Cardiac Regeneration) at Germans Trias i Pujol Research Institute (IGTP) and Banc de Sang i Teixits (BST).</p> <p>PeriCord has anti-inflammatory properties and opens the door to creating other drugs for conditions beyond the heart.</p>
None
Or read this on Eureka Alert